NPI | Name | Type | Address |
---|---|---|---|
MR. R.PH. Nader Saroufeem |
Individual |
3175 23rd St Ste 410 Astoria, NY |
|
DR. PHARM.D. Thu Oanh Thi Dang |
Individual |
1275 York Ave New York, NY |
|
MR. PHARMD Paul P Kao |
Individual |
27005 76th Ave New Hyde Park, NY |
|
MR. RPH Marc V Silbergleit |
Individual |
450 Clarkson Ave Box 36-pharmacy Brooklyn, NY |
|
RPH Shaun M Cobb |
Individual |
201 Dates Dr Suite 102 Ithaca, NY |
|
PHARMD Andrew Lin |
Individual |
1275 York Ave Schwartz 714 New York, NY |
|
DR. PHARM.D. Angela Gabriele Michael |
Individual |
1275 York Ave New York, NY |
|
DR. PHARM.D., BCOP Mei Ka Fong |
Individual |
Elm And Carlton St Buffalo, NY |
|
DR. PHARMD Lisa Marie Digrazia |
Individual |
1275 York Ave New York, NY |
|
DR. PHARM.D. Rachel L Garonce |
Individual |
1275 York Ave New York, NY |
|
DR. PHARM. D. Anand B Shah |
Individual |
1275 York Ave New York, NY |
|
PHARM.D. Daniel Van Meter |
Individual |
1275 York Ave New York, NY |
|
MR. RPH Hal Eugene Holtzman |
Individual |
259 1st St Mineola, NY |
|
DR. PHARM.D, BCOP Richard Ferrariz Tizon |
Individual |
1275 York Ave New York, NY |
|
DR. PHARMD, RPH Tuong Vy Le Nguyen |
Individual |
1650 Grand Concourse Bronx, NY |
|
PHARMD Kristen Beyer |
Individual |
1275 York Ave New York, NY |
|
Salma Afifi |
Individual |
1275 York Ave New York, NY |
|
DR. PHARM.D. Ryan Daley |
Individual |
1275 York Ave Schwartz Building, S-714 New York, NY |
|
DR. PHARMD Anthony Jarkowski III |
Individual |
601 Elmwood Ave Box 638 Rochester, NY |
|
MS. PHARMD Mabel Rodriguez |
Individual |
1275 York Ave New York, NY |
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
Taxonomy Code | 1835X0200X |
Specialization | Oncology |
Display Name | Oncology Pharmacist |
Taxonomy Group | Pharmacy Service Providers |
Taxonomy Classification | Pharmacist |
Definition | A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. |
Effective Date | September 30, 2009 |